VEGF-A downstream of MEK signaling weakened the above vasodilation response of ECs, indicating that VEGF-A played a new role in the resistance artery and provided a novel aspect of treating cardiovascular disease with VEGF-A (53). Here, VEGFA is linked to cardiovascular disorder.